Wells Fargo & Company »

Matinas Biopharma Hldgs shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Matinas Biopharma Hldgs (MTNB) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Matinas Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Matinas Biopharma Hldgs held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Matinas Biopharma Hldgs by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $193 102 1.89
2025-06-30 $91 102 0.89
2025-03-31 $52 102 0.52
2024-12-31 $51 102 0.51
2024-09-30 $3.9k 1.1k 3.54

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Matinas Biopharma Hldgs

Vanguard Group
Geode Capital Management
BlackRock
Sargent Investment Group
Holos Integrated Wealth
Renaissance Technologies
Northern Trust
State Street Corporation
Two Sigma Securities
Hrt Financial
Tower Research Capital
Rockefeller Capital Management
Farther Finance Advisors
Advisor Group Holdings
UBS Group

View all funds holding Matinas Biopharma Hldgs